Three years have passed since the opening of Microsoft's School of the Future in Philadelphia, a high-profile pilot project designed to kick urban education up a few notches with learning strategies from the corporate world. Two years ...READ»
We've written about Intralytix,
NovaBay, and Polymedix—companies developing drugs designed to
circumvent the growing problem of antibiotic resistance. Now a
hot-off-the-presses study from Nature suggests that ...READ»
Last year, I wrote about LS9, the scrappy Bay Area-based company that's engineering microbes to churn out transportation fuel. Now, LS9 has joined forces with Procter and Gamble--an upstart-titan partnership that could potentially ...READ»
Last fall, when we visited Wyeth Biotech's campus in Andover, MA, we were blown away by the management's off-the-beaten-path approach to drug development and innovation. Now the storyline has hit an unexpected twist: Officials at ...READ»
